Analysts expect Celldex Therapeutics, Inc. to report revenue of 751,010.85 for Q3 26, against a range of 687,233.51 to 814,788.19. The most recent reported quarter, Q2 26, came in at 22,000.00, a 96.8% miss against the 687,190.62 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 3.19 M | 1.18 M | 695,000.00 | 730,000.00 | 0.00 | 100,000.00 | 15,000.00 | 22,000.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 892,835.10 | 1.13 M | 1.08 M | 1.19 M | 1.12 M | 1.48 M | 845,242.65 | 742,690.88 | 814,788.19 | 1.32 M | 278,505.12 | 256,544.13 | 1.10 M | 1.94 M | 30.15 M | 35.10 M | ||||||||||
| Low Estimate | 818,207.96 | 1.03 M | 1.01 M | 1.01 M | 987,725.38 | 1.29 M | 705,685.49 | 631,690.36 | 687,233.51 | 1.20 M | 235,279.88 | 227,868.37 | 976,904.52 | 1.79 M | 27.03 M | 31.32 M | ||||||||||
| Consensus Estimate | 855,521.53 | 1.08 M | 1.05 M | 1.10 M | 1.05 M | 1.38 M | 775,464.07 | 687,190.62 | 751,010.85 | 1.26 M | 256,892.50 | 242,206.25 | 1.04 M | 1.87 M | 28.59 M | 33.21 M |
Analysts expect Celldex Therapeutics, Inc. to report earnings per share of -1.07 for Q3 26, against a range of -1.14 to -1.00. The most recent reported quarter, Q2 26, came in at -0.94, a 16.1% beat against the -1.12 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.64 | -0.71 | -0.81 | -0.85 | -1.01 | -1.22 | -1.18 | -0.94 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.63 | -0.68 | -0.72 | -0.77 | -0.88 | -0.89 | -1.11 | -1.04 | -1.00 | -1.00 | -1.00 | -0.86 | -1.12 | -1.15 | -0.80 | -0.75 | ||||||||||
| Low Estimate | -0.77 | -0.76 | -0.82 | -0.89 | -0.96 | -1.01 | -1.27 | -1.20 | -1.14 | -1.10 | -1.10 | -1.00 | -1.20 | -1.23 | -0.94 | -0.79 | ||||||||||
| Consensus Estimate | -0.70 | -0.72 | -0.77 | -0.83 | -0.92 | -0.95 | -1.19 | -1.12 | -1.07 | -1.05 | -1.05 | -0.93 | -1.16 | -1.19 | -0.87 | -0.77 |
Pull Wall Street consensus for Celldex Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CLDX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CLDX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CLDX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();